Anaplastic Lymphoma Kinase (ALK) Positive Neuroendocrine Tumor of Lung With Favorable Response to Alectinib (ALK Inhibitor).

Authors

Bipin Ghimire, Beaumont Health Resident
Ashbita Pokharel, Beaumont Health Resident
Ujjwal Karki, Beaumont Health Resident
Shrinjaya Thapa, Beaumont Health Resident
Mohammad Muhsin Chisti, Beaumont Health

Document Type

Article

Publication Date

5-2023

Publication Title

Clinical Lung Cancer

Volume

24

Issue

3

First Page

113

Last Page

116

Recommended Citation

Ghimire B, Pokharel A, Karki U, Thapa S, Chisti MM. Anaplastic Lymphoma Kinase (ALK) Positive Neuroendocrine Tumor of Lung With Favorable Response to Alectinib (ALK Inhibitor). Clin Lung Cancer. 2023 May;24(3):e113-e116. doi: 10.1016/j.cllc.2022.12.004. PMID: 36690569.

DOI

10.1016/j.cllc.2022.12.004.

ISSN

1938-0690

PubMed ID

36690569